Sun Pharma Sells Two US-Based Plants To Frontida BioPharm

New Delhi: Drug major Sun Pharmaceutical Industries has sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm Inc for an undisclosed amount. As part of its manufacturing consolidation in the US, one of the company's wholly-owned subsidiaries entered into an agreement with Frontida BioPharm Inc for divestment of two oral solid dosage manufacturing facilities located at Philadelphia and Aurora, ...